Viktor Roschke
Founder at Neuraly, Inc.
Net worth: 3 M $ as of 2024-04-29
Profile
Dr. Viktor Roschke is a Director & Chief Scientific Officer at Neuraly, Inc., a Chief Scientific Officer at D&D Pharmatech Co., Ltd.
and a Secretary & Director at Theraly Fibrosis, Inc. He is on the Board of Directors at Neuraly, Inc. and Theraly Fibrosis, Inc. Dr. Roschke was previously employed as a VP-Biopharmaceutical Research & Assay Development by Zyngenia, Inc., an Executive Director-Cell Biology by Human Genome Sciences, Inc., and a Chief Operating Officer by Teva Biopharmaceuticals USA, Inc. He received his doctorate degree from Novosibirsk State University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
D&D Pharma Tech Co., Ltd.
1.16% | 2024-05-01 | 120,509 ( 1.16% ) | 3 M $ | 2024-04-29 |
Viktor Roschke active positions
Companies | Position | Start |
---|---|---|
Theraly Fibrosis, Inc.
Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Theraly Fibrosis, Inc. operates as a commercial physical research company. The company was founded by Seulki Lee and is headquartered in Germantown, MD. | Director/Board Member | - |
Neuraly, Inc.
Neuraly, Inc. Miscellaneous Commercial ServicesCommercial Services Neuraly, Inc. provides healthcare services. The company was founded by Seulki Lee and Viktor Roschke in 2016 and is headquartered in Gaithersburg, MD. | Founder | 2015-12-31 |
D&D Pharma Tech Co., Ltd. | Chief Tech/Sci/R&D Officer | - |
Former positions of Viktor Roschke
Companies | Position | End |
---|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 2004-12-31 |
Teva Biopharmaceuticals USA, Inc.
Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Teva Biopharmaceuticals USA, Inc. develops and commercializes biological products. It uses albumin-fusion technology to develop and commercialize certain albumin-fusion proteins for therapeutic use. The company was founded by Craig A. Rosen, Steven C. Mayer, Indra Sanyal and Mark A. Rampy in 2005 and is headquartered in Rockville, MD. | Chief Operating Officer | - |
Zyngenia, Inc.
Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | Chief Tech/Sci/R&D Officer | - |
Training of Viktor Roschke
Novosibirsk State University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 6 |
---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Zyngenia, Inc.
Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | Retail Trade |
Teva Biopharmaceuticals USA, Inc.
Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Teva Biopharmaceuticals USA, Inc. develops and commercializes biological products. It uses albumin-fusion technology to develop and commercialize certain albumin-fusion proteins for therapeutic use. The company was founded by Craig A. Rosen, Steven C. Mayer, Indra Sanyal and Mark A. Rampy in 2005 and is headquartered in Rockville, MD. | Health Technology |
Neuraly, Inc.
Neuraly, Inc. Miscellaneous Commercial ServicesCommercial Services Neuraly, Inc. provides healthcare services. The company was founded by Seulki Lee and Viktor Roschke in 2016 and is headquartered in Gaithersburg, MD. | Commercial Services |
Theraly Fibrosis, Inc.
Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Theraly Fibrosis, Inc. operates as a commercial physical research company. The company was founded by Seulki Lee and is headquartered in Germantown, MD. | Health Technology |
D&D Pharma Tech Co., Ltd. |
- Stock Market
- Insiders
- Viktor Roschke